HEADER TRANSFERASE 25-NOV-19 6V2U TITLE CRYSTAL STRUCTURE OF THE INSECT CELL-EXPRESSED WT-BRAF KINASE IN TITLE 2 COMPLEX WITH DABRAFENIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTO-ONCOGENE B-RAF,P94,V-RAF MURINE SARCOMA VIRAL ONCOGENE COMPND 5 HOMOLOG B1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC DUAL KEYWDS BRAF, MEK1, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.LI,G.GONZALEZ DEL-PINO,E.PARK,M.J.ECK REVDAT 2 11-OCT-23 6V2U 1 REMARK REVDAT 1 02-DEC-20 6V2U 0 JRNL AUTH K.LI,G.GONZALEZ DEL-PINO,E.PARK,M.J.ECK JRNL TITL CRYSTAL STRUCTURE OF THE INSECT CELL-EXPRESSED WT-BRAF JRNL TITL 2 KINASE IN COMPLEX WITH DABRAFENIB JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 6859 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.282 REMARK 3 R VALUE (WORKING SET) : 0.281 REMARK 3 FREE R VALUE : 0.309 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.750 REMARK 3 FREE R VALUE TEST SET COUNT : 326 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.4800 - 4.7600 0.95 3311 181 0.2684 0.2954 REMARK 3 2 3.9200 - 3.7800 0.96 3222 145 0.2970 0.3303 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.520 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.470 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 81.83 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 79.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6V2U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-DEC-19. REMARK 100 THE DEPOSITION ID IS D_1000245508. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-NOV-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6877 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.780 REMARK 200 RESOLUTION RANGE LOW (A) : 41.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.36780 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.4700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.540 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5CSW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS PH 7, 2.5 M SODIUM REMARK 280 CHLORIDE, 100 MM MAGNESIUM CHLORIDE, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.29150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 44.80900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 44.80900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 41.14575 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 44.80900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 44.80900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 123.43725 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 44.80900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 44.80900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 41.14575 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 44.80900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 44.80900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 123.43725 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 82.29150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 441 REMARK 465 GLY A 442 REMARK 465 GLY A 443 REMARK 465 ARG A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 ASP A 448 REMARK 465 GLY A 596 REMARK 465 LEU A 597 REMARK 465 ALA A 598 REMARK 465 THR A 599 REMARK 465 VAL A 600 REMARK 465 LYS A 601 REMARK 465 SER A 602 REMARK 465 ARG A 603 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 LEU A 613 REMARK 465 PRO A 722 REMARK 465 LYS A 723 REMARK 465 GLY B 441 REMARK 465 GLY B 442 REMARK 465 GLY B 443 REMARK 465 ARG B 444 REMARK 465 ASP B 445 REMARK 465 SER B 446 REMARK 465 SER B 447 REMARK 465 ASP B 448 REMARK 465 VAL B 487 REMARK 465 THR B 488 REMARK 465 ALA B 489 REMARK 465 PRO B 490 REMARK 465 ALA B 598 REMARK 465 THR B 599 REMARK 465 VAL B 600 REMARK 465 LYS B 601 REMARK 465 SER B 602 REMARK 465 ARG B 603 REMARK 465 TRP B 604 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 LEU B 613 REMARK 465 SER B 614 REMARK 465 GLY B 615 REMARK 465 LEU B 721 REMARK 465 PRO B 722 REMARK 465 LYS B 723 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 488 OG1 CG2 REMARK 470 GLN A 493 CG CD OE1 NE2 REMARK 470 GLU A 501 CG CD OE1 OE2 REMARK 470 ARG A 719 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 493 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 450 9.31 -66.03 REMARK 500 PHE A 468 116.06 -161.42 REMARK 500 ALA A 489 79.15 53.49 REMARK 500 ILE A 543 -53.19 -128.42 REMARK 500 ARG A 575 -11.56 79.13 REMARK 500 ASP A 576 44.02 -148.70 REMARK 500 LEU A 588 -52.75 -144.49 REMARK 500 SER A 616 67.75 -169.83 REMARK 500 ARG A 626 -85.14 -70.07 REMARK 500 GLN A 628 -6.45 -171.38 REMARK 500 ASP A 629 -66.88 -99.87 REMARK 500 LYS A 630 -123.34 -123.35 REMARK 500 TRP B 450 -117.98 -65.14 REMARK 500 GLU B 451 112.36 46.27 REMARK 500 LEU B 525 120.07 69.69 REMARK 500 ILE B 543 -51.64 -128.48 REMARK 500 ARG B 575 -12.49 79.91 REMARK 500 ASP B 576 44.88 -149.32 REMARK 500 LEU B 588 -53.29 -144.44 REMARK 500 GLN B 628 -7.76 -159.55 REMARK 500 ASP B 629 33.72 -97.54 REMARK 500 LYS B 630 168.68 141.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P06 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P06 B 801 DBREF 6V2U A 445 723 UNP P15056 BRAF_HUMAN 445 723 DBREF 6V2U B 445 723 UNP P15056 BRAF_HUMAN 445 723 SEQADV 6V2U GLY A 441 UNP P15056 EXPRESSION TAG SEQADV 6V2U GLY A 442 UNP P15056 EXPRESSION TAG SEQADV 6V2U GLY A 443 UNP P15056 EXPRESSION TAG SEQADV 6V2U ARG A 444 UNP P15056 EXPRESSION TAG SEQADV 6V2U GLY B 441 UNP P15056 EXPRESSION TAG SEQADV 6V2U GLY B 442 UNP P15056 EXPRESSION TAG SEQADV 6V2U GLY B 443 UNP P15056 EXPRESSION TAG SEQADV 6V2U ARG B 444 UNP P15056 EXPRESSION TAG SEQRES 1 A 283 GLY GLY GLY ARG ASP SER SER ASP ASP TRP GLU ILE PRO SEQRES 2 A 283 ASP GLY GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SEQRES 3 A 283 SER PHE GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP SEQRES 4 A 283 VAL ALA VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO SEQRES 5 A 283 GLN GLN LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU SEQRES 6 A 283 ARG LYS THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY SEQRES 7 A 283 TYR SER THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP SEQRES 8 A 283 CYS GLU GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE SEQRES 9 A 283 GLU THR LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA SEQRES 10 A 283 ARG GLN THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SEQRES 11 A 283 SER ILE ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE SEQRES 12 A 283 LEU HIS GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY SEQRES 13 A 283 LEU ALA THR VAL LYS SER ARG TRP SER GLY SER HIS GLN SEQRES 14 A 283 PHE GLU GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO SEQRES 15 A 283 GLU VAL ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE SEQRES 16 A 283 GLN SER ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU SEQRES 17 A 283 LEU MET THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN SEQRES 18 A 283 ARG ASP GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SEQRES 19 A 283 SER PRO ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS SEQRES 20 A 283 ALA MET LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS SEQRES 21 A 283 ARG ASP GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER SEQRES 22 A 283 ILE GLU LEU LEU ALA ARG SER LEU PRO LYS SEQRES 1 B 283 GLY GLY GLY ARG ASP SER SER ASP ASP TRP GLU ILE PRO SEQRES 2 B 283 ASP GLY GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SEQRES 3 B 283 SER PHE GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP SEQRES 4 B 283 VAL ALA VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO SEQRES 5 B 283 GLN GLN LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU SEQRES 6 B 283 ARG LYS THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY SEQRES 7 B 283 TYR SER THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP SEQRES 8 B 283 CYS GLU GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE SEQRES 9 B 283 GLU THR LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA SEQRES 10 B 283 ARG GLN THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SEQRES 11 B 283 SER ILE ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE SEQRES 12 B 283 LEU HIS GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY SEQRES 13 B 283 LEU ALA THR VAL LYS SER ARG TRP SER GLY SER HIS GLN SEQRES 14 B 283 PHE GLU GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO SEQRES 15 B 283 GLU VAL ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE SEQRES 16 B 283 GLN SER ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU SEQRES 17 B 283 LEU MET THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN SEQRES 18 B 283 ARG ASP GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SEQRES 19 B 283 SER PRO ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS SEQRES 20 B 283 ALA MET LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS SEQRES 21 B 283 ARG ASP GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER SEQRES 22 B 283 ILE GLU LEU LEU ALA ARG SER LEU PRO LYS HET P06 A 801 35 HET CL A 802 1 HET P06 B 801 35 HETNAM P06 DABRAFENIB HETNAM CL CHLORIDE ION HETSYN P06 N-{3-[5-(2-AMINOPYRIMIDIN-4-YL)-2-TERT-BUTYL-1,3- HETSYN 2 P06 THIAZOL-4-YL]-2-FLUOROPHENYL}-2,6- HETSYN 3 P06 DIFLUOROBENZENESULFONAMIDE FORMUL 3 P06 2(C23 H20 F3 N5 O2 S2) FORMUL 4 CL CL 1- HELIX 1 AA1 PRO A 453 ILE A 457 5 5 HELIX 2 AA2 THR A 491 LYS A 507 1 17 HELIX 3 AA3 LEU A 537 ILE A 543 1 7 HELIX 4 AA4 GLU A 549 LYS A 570 1 22 HELIX 5 AA5 LYS A 578 ASN A 580 5 3 HELIX 6 AA6 SER A 616 MET A 620 5 5 HELIX 7 AA7 PRO A 622 ARG A 626 5 5 HELIX 8 AA8 SER A 634 GLY A 652 1 19 HELIX 9 AA9 ASN A 661 GLY A 672 1 12 HELIX 10 AB1 PRO A 686 LEU A 697 1 12 HELIX 11 AB2 LYS A 700 ARG A 704 5 5 HELIX 12 AB3 LEU A 706 LEU A 721 1 16 HELIX 13 AB4 PRO B 492 LYS B 507 1 16 HELIX 14 AB5 SER B 536 ILE B 543 1 8 HELIX 15 AB6 GLU B 549 LYS B 570 1 22 HELIX 16 AB7 LYS B 578 ASN B 580 5 3 HELIX 17 AB8 GLU B 586 LEU B 588 5 3 HELIX 18 AB9 SER B 616 MET B 620 5 5 HELIX 19 AC1 PRO B 622 MET B 627 1 6 HELIX 20 AC2 SER B 634 GLY B 652 1 19 HELIX 21 AC3 ASN B 661 GLY B 672 1 12 HELIX 22 AC4 PRO B 686 LEU B 697 1 12 HELIX 23 AC5 LYS B 700 ARG B 704 5 5 HELIX 24 AC6 LEU B 706 ALA B 718 1 13 SHEET 1 AA1 5 THR A 458 SER A 465 0 SHEET 2 AA1 5 THR A 470 LYS A 475 -1 O VAL A 471 N GLY A 464 SHEET 3 AA1 5 ASP A 479 MET A 484 -1 O VAL A 482 N TYR A 472 SHEET 4 AA1 5 ALA A 526 GLN A 530 -1 O ILE A 527 N LYS A 483 SHEET 5 AA1 5 PHE A 516 SER A 520 -1 N MET A 517 O VAL A 528 SHEET 1 AA2 3 GLY A 534 SER A 536 0 SHEET 2 AA2 3 ILE A 582 HIS A 585 -1 O LEU A 584 N SER A 535 SHEET 3 AA2 3 THR A 589 ILE A 592 -1 O LYS A 591 N PHE A 583 SHEET 1 AA3 5 THR B 458 SER B 465 0 SHEET 2 AA3 5 THR B 470 LYS B 475 -1 O VAL B 471 N GLY B 464 SHEET 3 AA3 5 ASP B 479 MET B 484 -1 O VAL B 482 N TYR B 472 SHEET 4 AA3 5 ALA B 526 GLN B 530 -1 O ILE B 527 N LYS B 483 SHEET 5 AA3 5 PHE B 516 SER B 520 -1 N GLY B 518 O VAL B 528 SHEET 1 AA4 2 ILE B 582 HIS B 585 0 SHEET 2 AA4 2 THR B 589 ILE B 592 -1 O THR B 589 N HIS B 585 CISPEP 1 LYS A 522 PRO A 523 0 1.14 CISPEP 2 LYS B 522 PRO B 523 0 0.87 SITE 1 AC1 14 VAL A 471 LYS A 483 LEU A 505 LEU A 514 SITE 2 AC1 14 PHE A 516 ILE A 527 THR A 529 GLN A 530 SITE 3 AC1 14 TRP A 531 CYS A 532 PHE A 583 GLY A 593 SITE 4 AC1 14 ASP A 594 PHE A 595 SITE 1 AC2 4 TRP A 450 ARG A 506 TRP B 450 ARG B 506 SITE 1 AC3 16 SER B 465 PHE B 468 VAL B 471 LYS B 483 SITE 2 AC3 16 LEU B 505 LEU B 514 PHE B 516 ILE B 527 SITE 3 AC3 16 THR B 529 GLN B 530 TRP B 531 CYS B 532 SITE 4 AC3 16 PHE B 583 GLY B 593 ASP B 594 PHE B 595 CRYST1 89.618 89.618 164.583 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011158 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011158 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006076 0.00000